GoalFi

Crizac IPO Allotment Today: Strong GMP Signals Bright Listing After 116x Subscription

All eyes are on the IPO allotment status of Crizac Ltd, which is likely to be announced today following one of the most oversubscribed SME offerings in recent months. The IPO saw an astounding 116x total subscription, with enthusiastic participation across retail, HNI, and institutional investor categories.Crizac Ltd known for its presence in premium education support services and exclusive distribution of luxury writing instruments had floated a public issue of ₹43.4 crore in the price band of ₹88–₹92 per share. The IPO was open from June 27 to July 1, and received strong demand, particularly from HNIs who alone bid over 200 times their quota.

Adding to the buzz, the grey market premium (GMP) for Crizac shares is currently hovering between ₹55–₹60, indicating a possible listing price of ₹147–₹152, which is 65% above the upper issue price.Investors who applied can check their allotment status on the registrar’s website, Bigshare Services Pvt Ltd, by entering their PAN, application number, or DP/client ID.

The listing date is tentatively scheduled for July 3, and market participants expect a strong debut, supported by solid fundamentals, brand recall, and low equity float.

Disclaimer: This article is intended solely for informational purposes and does not constitute investment advice or a recommendation in any form. Investing in the securities market involves risks. Please read all scheme-related documents carefully before investing. The views and opinions expressed are based on publicly available information and internal analysis. GoalFi shall not be held responsible for any decisions made based on this content. Investors are advised to exercise their own judgment or consult a financial advisor before making investment decisions. Powered by a blend of human expertise and AI-assisted content tools for clarity and precision.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share this Post and Follow us on :

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor

Facebook
Twitter
LinkedIn